Insider track record
OtherAcross 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Carter Todd Alfred. Officer active across 1 company, notably Voyager Therapeutics, Inc.. In total, 14 disclosures have been published. Split: 0 buy · 9 sells. Total volume traded: €138k. Activity tracked since 31 December 2022. The latest transaction was filed on 20 February 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations14 total
3,305 shares@ US$4.268.1% of flowCommon StockSEC:0001104659-25-016522:0
5,413 shares@ US$4.4514.1% of flowCommon StockSEC:0001104659-25-012200:0
1,191 shares@ US$5.133.6% of flowCommon StockSEC:0001104659-25-003772:0
602 shares@ US$7.682.6% of flowCommon StockSEC:0001104659-24-026554:0
38,500 shares0Common StockSEC:0001104659-24-024993:0
1,266 shares@ US$7.185.0% of flowCommon StockSEC:0001104659-24-005244:0
5,000 shares@ US$2.8512.1% of flowCommon StockSEC:0001104659-23-101631:0
5,500 shares@ US$10.8032.8% of flowCommon StockSEC:0001104659-23-079686:0
5,000 shares@ US$2.857.9% of flowCommon StockSEC:0001104659-23-078152:0
2,193 shares@ US$7.769.6% of flowCommon StockSEC:0001104659-23-035642:0
34,000 shares0Common StockSEC:0001104659-23-024423:0
797 shares@ US$7.673.4% of flowCommon StockSEC:0001104659-23-022430:0
706 shares@ US$9.573.8% of flowCommon StockSEC:0001104659-23-005050:0
388 shares@ US$5.171.1% of flowCommon StockSEC:0001104659-23-002718:0